Clinical Cancer Research Grant

From Rising Tide Foundation

Rising Tide Foundation promotes freedom and prosperity for all, advocating for a market economy, limited government, and the rule of law. They believe in individual flourishing through voluntary exchange and aim to address poverty by respecting individual dignity and moral agency. Their goal is to support projects that eliminate obstacles for creative individuals, offering a "hand up" instead of a "hand-out," and oppose big-government and crony capitalism interventions.

Type of Support

Overview

The grant program is guided by principles of patient involvement, aiming to establish a new norm in clinical cancer research that treats patients as partners. It supports interventional clinical trials not funded by commercial entities, with a requirement for research to show patient impact within 3 to 5 years and to start within 6 months of award notification. The funding approach is rooted in patient centricity, ensuring research aligns with improving patient quality of life. Projects should focus on short time frames for maximum impact, and align with strategic focus areas developed with expert input. These areas include improving patient outcomes with minimal toxicity, enhancing early detection and intervention, and advancing research in underserved regions. The foundation encourages partnerships to maximize reach and expects co-funding plans from applicants. Specific focus areas include therapy optimization, disease and treatment burden, implementation research, early detection, early intervention, and advancing cancer research in Sub-Saharan Africa.

Eligibility

Organization's Location
pariatur officia
Program Location
ex
Organization Type
Velit nostrud
Nulla elit
Other
  • velit duis magna amet quis occaecat enim
  • dolore et ullamco fugiat ut exercitation fugiat laboris consectetur et ex velit
  • consectetur deserunt occaecat tempor cillum deserunt aute nostrud ex dolor
  • amet mollit in ea elit incididunt voluptate anim velit in eiusmod eiusmod
  • ullamco velit officia sit minim esse ipsum laboris dolor velit sunt amet
not specified

Submission

Schedule
Step 1: Lorem velit fugiat
Application deadline
Dec 18, 2024
Step 2: dolor nisi (laboris qui)